Clinical depression, antidepressant use and risk of future cardiovascular disease

European Journal of Epidemiology

Volumn 28, Issue 7, 2013, Pages 589-595

  Rahman, Iffat ^a   Humphreys, Keith ^a   Bennet, Anna Michaela ^a   Ingelsson, Erik ^a   Pedersen, Nancy Lee ^a   Magnusson, Patrik Karl Erik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antidepressants; Cardiovascular disease; Depression; Epidemiology

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE A INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DEPRESSION; DISEASE ASSOCIATION; EXPOSURE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; RISK ASSESSMENT;

AGED; ANTIDEPRESSIVE AGENTS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DEPRESSION; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; SOCIOECONOMIC FACTORS; STROKE; SWEDEN;

EID: 84884291930     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-013-9821-z     Document Type: Article

References (46)

1. Rutledge T, Reis SE, Olson MB, et al. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: the NHLBI-sponsored WISE study. Arch Gen Psychiatry. 2006;63:874-80.
2. Wassertheil-Smoller S, Shumaker S, Ockene J, et al. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med. 2004;164:289-98.
3. Whooley MA. Depression and cardiovascular disease: healing the broken-hearted. JAMA. 2006;295:2874-81.
4. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300:2379-88.
5. Wouts L, Oude Voshaar RC, Bremmer MA, Buitelaar JK, Penninx BW, Beekman AT. Cardiac disease, depressive symptoms, and incident stroke in an elderly population. Arch Gen Psychiatry. 2008;65:596-602.
6. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27:2763-74.
7. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306:1241-9.
8. Kendler KS, Gardner CO, Fiske A, Gatz M. Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity. Arch Gen Psychiatry. 2009;66:857-63.
9. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry. 1997;54:915-22.
10. Janszky I, Ahnve S, Lundberg I, Hemmingsson T. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol. 2010;56:31-7.
11. Stansfeld SA, Smith GD, Marmot M. Association between physical and psychological morbidity in the Whitehall II Study. J Psychosom Res. 1993;37:227-38.
12. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24-31.
13. Miwa K, Tanaka M, Okazaki S, et al. Association between interleukin-6 levels and first-ever cerebrovascular events in patients with vascular risk factors. Arterioscler Thromb Vasc Biol. 2013;33:400-5.
14. Leonard BE, Song C. Stress and the immune system in the etiology of anxiety and depression. Pharmacol Biochem Behav. 1996;54:299-303.
15. Marano G, Harnic D, Lotrionte M, et al. Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications. Expert Rev Cardiovasc Ther. 2009;7:1123-47.
16. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:580-92.
17. Roose SP. Treatment of depression in patients with heart disease. Biol Psychiatry. 2003;54:262-8.
18. Blanchette CM, Simoni-Wastila L, Zuckerman IH, Stuart B. A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population. Ann Epidemiol. 2008;18:316-21.
19. Hamer M, David Batty G, Seldenrijk A, Kivimaki M. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J. 2011;32:437-42.
20. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med. 2009;169:2128-39.
21. Tata LJ, West J, Smith C, et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart. 2005;91:465-71.
22. Kimmel SE, Schelleman H, Berlin JA, et al. The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression. Br J Clin Pharmacol. 2011;72:514-7.
23. Monster TB, Johnsen SP, Olsen ML, McLaughlin JK, Sorensen HT. Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am J Med. 2004;117:732-7.
24. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104:1894-8.
25. Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation. 2003;108:32-6.
26. Meier CR, Schlienger RG, Jick H. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol. 2001;52:179-84.
27. O'Connor CM, Jiang W, Kuchibhatla M, et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med. 2008;168:2232-7.
28. Zahradnik I, Minarovic I, Zahradnikova A. Inhibition of the cardiac L-type calcium channel current by antidepressant drugs. J Pharmacol Exp Ther. 2008;324:977-84.
29. Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des. 2004;10:2463-75.
30. Ottervanger JP, Stricker BH, Huls J, Weeda JN. Bleeding attributed to the intake of paroxetine. Am J Psychiatry. 1994;151:781-2.
31. Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther. 2000;68:435-42.
32. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
33. Medicinalstyrelsen K. International Statistical Classification of Diseases, Injuries and Causes of Death, 1955 revision adapted for indexing of hospitals. Stockholm; 1965.
34. Socialstyrelsen. International Statistical Classification of Diseases, Injuries and Causes of Death, 1965 revision adapted for indexing of hospitals; 1968.
35. Socialstyrelsen. Svensk version av International Classification of Diseases, Ninth Revision (ICD-9); 1987.
36. Socialstyrelsen. Svensk version av International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10); 2010. Report No.: 2010-11-13.
37. Therneau TM, Grambsch PM. Modelling Survival Data: extending the Cox model: Springer; 2000.
38. Carlin JB, Galati JC, Royston P. A new framework for managing and analyzing multiply imputed data in Stata. Stata J. 2008;8:49-67.
39. Grobbee DE, Hoes AW. Confounding and indication for treatment in evaluation of drug treatment for hypertension. BMJ. 1997;315:1151-4.
40. Nabi H, Kivimaki M, Suominen S, Koskenvuo M, Singh-Manoux A, Vahtera J. Does depression predict coronary heart disease and cerebrovascular disease equally well? The Health and Social Support Prospective Cohort Study. Int J Epidemiol. 2010;39:1016-24.
41. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106-16.
42. van Melle JP, de Jonge P, Honig A, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry. 2007;190:460-6.
43. Mead GE, Hsieh CF, Lee R, et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012;11:CD009286.
44. Witte TK, Timmons KA, Fink E, Smith AR, Joiner TE. Do major depressive disorder and dysthymic disorder confer differential risk for suicide? J Affect Disord. 2009;115:69-78.
45. Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimaki M, Batty GD. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ. 2012;345:e4933.
46. Salmi P. Äldres behov av psykiatrisk vård och stöd; 2012 2012-02.